Mohammad Soheilypour
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$4.4MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $4.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2023 | NIH | STTR Phase I Novel probiotics to mitigate xenobiotic toxicity through microbial biotransformation | $276K | NEXILICO, INC. |
| Jun 1, 2023 | NSF | SBIR Phase II SBIR Phase II:An omics-based computational drug design and discovery platform for next generation microbiome therapeutics | $1.6M | NEXILICO, INC. |
| May 30, 2023 | NSF | SBIR Phase II SBIR Phase II: An omics-based computational drug design and discovery platform for next generation microbiome therapeutics | $1.6M | NEXILICO, INC. |
| Apr 26, 2022 | NIH | STTR Phase I Computational prediction of gut microbiome-mediated drug metabolism | $55K | NEXILICO, INC. |
| Apr 14, 2021 | NIH | STTR Phase I Computational prediction of gut microbiome-mediated drug metabolism | $325K | NEXILICO, INC. |
| Feb 1, 2020 | NSF | SBIR Phase I SBIR Phase I: An omics-based computational platform for the personalization of gut microbiome therapeutics | $225K | NEXILICO, INC. |
| May 2, 2019 | NIH | SBIR Phase I A Predictive Computational Platform for Gut Microbiome Precision Medicine | $225K | NEXILICO, INC. |
Peer ranks
Federal funding#339
Awards as PI#250
Patents#273
Companies
- NEXILICO, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.